Φορτώνει......
Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
BACKGROUND: Neoadjuvant chemotherapy for breast cancer leads to considerable variability in clinical responses, with only 10 to 20% of cases achieving complete pathologic responses (pCR). Biological and clinical factors that determine the extent of pCR are incompletely understood. Mounting evidence...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Genome Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4240891/ https://ncbi.nlm.nih.gov/pubmed/25419236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-014-0080-8 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|